Treatment options for breast cancer and bone metastases

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Übersichtsartikel

2 Zitate (Scopus)

Abstract

The most common destination for breast cancer metastases is bone. If bone metastases are detected, treatment algorithms should include the continuation of cytoreductive therapy with the addition of treatment to counter skeletal-related events, including bone pain. The range of current treatment options includes bisphosphonates, surgical intervention to improve structural integrity and palliative focal radiotherapy. This article focuses on the role of bisphosphonate therapy in metastatic breast cancer. Bisphosphonate therapy significantly reduces the impact of skeletal-related events, reduces bone pain and increases patient quality of life. Our current understanding is that bisphosphonates may also disrupt the metastatic process and reduce the development of bone lesions. Ultimately, this may lead to further expansion of bisphosphonate-based therapy in the future.

OriginalspracheEnglisch
Seiten (von - bis)149-163
Seitenumfang15
FachzeitschriftWomen's Health
Jahrgang5
Ausgabenummer2
DOIs
PublikationsstatusVeröffentlicht - März 2009
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Treatment options for breast cancer and bone metastases“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren